Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction
Open Access
- 1 December 2001
- Vol. 86 (6) , 638-642
- https://doi.org/10.1136/heart.86.6.638
Abstract
OBJECTIVE To investigate the relation between brain natriuretic peptide (BNP) concentrations and left ventricular remodelling characteristics after acute myocardial infarction. DESIGN Consecutive sample prospective cohort study. SETTING District general hospital coronary care unit in the north of England. PATIENTS 133 initial survivors of a first myocardial infarction who received thrombolytic treatment. INTERVENTIONS Patients had transthoracic echocardiography and BNP concentrations measured at three to seven days (early) and two months (late). MAIN OUTCOME MEASURES Wall motion index ⩽ 1.2, end systolic left ventricular volume index and mortality at one year. RESULTS Patients with an early wall motion index of ⩽ 1.2 had higher early and late BNP concentrations (early BNP mean (SEM) 629 (76.2) pg/ml v 334 (20.8) pg/ml, p = 0.001 and late BNP 584 (79.5) pg/mlv 343 (25.0) pg/ml, p = 0.001). Patients with an increase in end systolic left ventricular volume index of > 10% also had higher early and late BNP concentrations (early BNP p = 0.034 and late BNP p = 0.001). Early BNP was significantly associated with one year mortality (p = 0.003). CONCLUSIONS Higher BNP concentrations early after first myocardial infarction are associated with adverse left ventricular remodelling characteristics. This may help explain why BNP is such a strong predictor of outcome after myocardial infarction.Keywords
This publication has 25 references indexed in Scilit:
- Aortic valve tumour trapped in the right coronary ostiumHeart, 2000
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Diagnostic Value of B-Type Natriuretic Peptide Concentrations in Patients With Acute Myocardial InfarctionPublished by Elsevier ,1996
- Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunctionThe American Journal of Cardiology, 1996
- Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarctionJournal of the American College of Cardiology, 1995
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionPublished by Elsevier ,1993
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- Effect of streptokinase on left ventricular modeling and function after myocardial infarction: The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) trialJournal of the American College of Cardiology, 1989
- A new natriuretic peptide in porcine brainNature, 1988
- TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTIONThe Lancet, 1988